# OnCo record radiant-3-4 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/radiant-3-4/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "radiant-3-4", "NCT00510068" ;
  schema:name "RADIANT-3 and RADIANT-4"@en ;
  schema:description "The two trials that made everolimus a standard pill for pancreatic, lung and gut neuroendocrine tumours."@en ;
  schema:url <https://onco.cc/trials/radiant-3-4/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00510068> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2007-07" ;
  onco:cancers <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/pancreatic-net/>, <https://onco.cc/cancers/small-intestinal-net/>, <https://onco.cc/cancers/lung-net/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/pi3k-akt-mtor-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/everolimus/> ;
  onco:companies <https://onco.cc/companies/novartis/> ;
  onco:people <https://onco.cc/people/james-yao/> .